Viewing Study NCT05156320


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-02 @ 9:24 AM
Study NCT ID: NCT05156320
Status: COMPLETED
Last Update Posted: 2025-03-07
First Post: 2021-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
Sponsor: Scholar Rock, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SRK-015-003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators